Target intelligence / Profile preview

Muscle cell differentiation

Molecular classification
Biological process
01

Overview

Muscle cell differentiation, also known as myogenesis, is the biological process by which multipotent precursor cells (myoblasts) transform into specialized, mature muscle fibers. This transition is governed by a hierarchical network of transcription factors known as Myogenic Regulatory Factors (MRFs), which include MyoD, Myf5, Myogenin, and MRF4 [StudySmarter 2024, PubMed 7880524]. During this process, myoblasts exit the cell cycle and initiate a muscle-specific gene expression program that leads to the synthesis of contractile proteins like actin and myosin, eventually resulting in the fusion of cells into multinucleated myofibers [Britannica 2024, Wikipedia 2024]. Pathological dysregulation of this process is a hallmark of various conditions, including muscular dystrophies, age-related sarcopenia, and cancer-induced cachexia [PMC3661141, PMC10675712]. While the differentiation process itself is a biological pathway rather than a single protein, specific nodes within it are targeted therapeutically; for instance, myostatin inhibitors and HDAC inhibitors (like Givinostat) are used to promote muscle growth or repair by modulating the myogenic program [PMC4120392, PMC10675712].

Other names
MyogenesisMyogenic differentiationSkeletal muscle differentiation
02

Mechanism of action

Inhibition of negative regulators of muscle growth (e.g., myostatin), epigenetic modulation via histone deacetylase (HDAC) inhibition to promote muscle-specific gene transcription, and activation of myogenic regulatory factor signaling pathways.

03

Biological functions

Cell differentiationMuscle developmentTissue regenerationCell cycle withdrawalMyofiber fusion
04

Disease associations

Muscular dystrophySarcopeniaCancer cachexiaRhabdomyosarcomaVolumetric muscle loss
05

Safety considerations

Potential for off-target effects on non-muscle tissuesRisk of uncontrolled muscle hypertrophy affecting cardiac functionPossible oncogenic risk if cell cycle exit is improperly regulatedHistorical challenges with clinical efficacy and functional improvement in human trials for myostatin inhibitors
06

Interacting drugs

Givinostat

5 more in the full profile.

07

Biomarkers

Myogenin (MYOG)Myoblast determination protein 1 (MyoD1)Creatine kinase (CK)DesminMyosin heavy chain (MHC)Paired box protein Pax-7

Beyond the preview

Go deeper on Muscle cell differentiation.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Muscle cell differentiation.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call